Evidence map›Paper›PMID 36198098›Full record

ArticleNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2023

Immediate Switching to Reduced Nicotine Cigarettes in a U.S.-Based Sample: The Impact on Cannabis Use and Related Variables at 20 Weeks.

Ellen Meier, Nathan Rubin, Sarah S Dermody, Katelyn M Tessier, Stephen S Hecht, Sharon Murphy, Joni Jensen, Eric C Donny, Mustafa al'Absi, David Drobes and 6 more

Abstract read
In one paragraph

Article in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ellen MeierDepartment of Psychology, University of Wisconsin-Stevens Point, Stevens Point, WI, USA.ORCID 0000-0002-5331-0630
Nathan RubinBiostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Sarah S DermodySchool of Psychological Science, Oregon State University, Corvallis, OR, USA.
Katelyn M TessierBiostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Stephen S HechtUniversity of Minnesota Masonic Cancer Center, 717 Delaware St. SE, Minneapolis, MN 55414, USA.ORCID 0000-0001-7228-1356
Sharon MurphyUniversity of Minnesota Masonic Cancer Center, 717 Delaware St. SE, Minneapolis, MN 55414, USA.
Joni JensenUniversity of Minnesota Masonic Cancer Center, 717 Delaware St. SE, Minneapolis, MN 55414, USA.
Eric C DonnyDepartment of Social Science and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USA.ORCID 0000-0003-3288-9652
Mustafa al'AbsiDepartment of Family Medicine and BioBehavioral Health, University of Minnesota Medical School, Duluth, MN, USA.
David DrobesDepartments of Oncologic Sciences and Psychology, University of South Florida, Tampa, FL, USA.
Joe KoopmeinersUniversity of Minnesota Masonic Cancer Center, 717 Delaware St. SE, Minneapolis, MN 55414, USA.
Rachel Denlinger-ApteDepartment of Social Science and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USA.ORCID 0000-0002-3182-7188
Jennifer W TideyDepartment of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA.
Ryan VandreyJohns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
Cole ThorneDepartment of Psychology, University of Wisconsin-Stevens Point, Stevens Point, WI, USA.
Dorothy HatsukamiUniversity of Minnesota Masonic Cancer Center, 717 Delaware St. SE, Minneapolis, MN 55414, USA.ORCID 0000-0002-1108-2609

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIAU54DA031659 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HATSUKAMI, DOROTHY K · 2011 to 2022
$64.7M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
Stress, Appetite, and Smoking RelapseR01DA027232 · NIDA · UNIVERSITY OF MINNESOTA · PI AL'ABSI, MUSTAFA, LEE, DUSTIN CLARK · 2010 to 2025
$4.6M
Stress Response and Opioid Dysfunction in Nicotine DependenceR01DA016351 · NIDA · UNIVERSITY OF MINNESOTA DULUTH · PI AL'ABSI, MUSTAFA · 2003 to 2023
$4.5M
FDA HHSNCATS NIH HHS UL1TR0002494NCATS NIH HHS UL1 TR002494NCI NIH HHS P30 CA077598NIDA NIH HHS R01 DA016351NIDA NIH HHS R01 DA027232NIDA NIH HHS U54 DA031659
6 · The paper itself

Abstract

introductionThe FDA proposed rule-making to reduce nicotine in cigarettes to minimally addictive levels. Research suggests decreasing nicotine levels (i.e. very low nicotine content cigarettes [VLNCs]) produced greater quit attempts, reduced smoking, and reduced exposure to harmful constituents among smokers. The impact of long-term VLNC use among people who co-use cigarettes and cannabis on non-tobacco-specific toxicant and carcinogen exposure has not been investigated. AIMS AND

methodsThis study presents secondary analyses of a controlled clinical trial examining switching to VLNC (versus a normal nicotine cigarettes control group [NNCs]) between people who co-use cigarettes and cannabis (n = 174) versus smoked cigarettes (n = 555). Linear mixed-effects models compared changes in smoking behavior, and tobacco-specific (i.e. total nicotine equivalents [TNE], 4-[methylnitrosamino]-1-[3-pyridyl]-1-butanone [NNK; total NNAL]) and non-tobacco-specific (i.e. carbon monoxide (CO), 2-cyanoethylmercapturic acid [CEMA], phenanthrene tetraol [PheT]) toxicant and carcinogen exposure at week 20 (with random intercept for participants). Cannabis use was measured among co-use groups.

resultsCO was significantly lower only among the cigarette-only group assigned VLNCs (interaction: p = .015). Although both VLNC groups demonstrated decreased CEMA, greater decreases emerged among the cigarette-only group (interaction: p = .016). No significant interactions emerged for TNE, cigarettes per day (CPD), NNAL, and PheT (ps > .05); both VLNC groups decreased in TNE, CPD, and NNAL. Only the cigarette-only group assigned VLNCs demonstrated decreased PheT (p < .001). The VLNC co-use group showed increased cannabis use over time (p = .012; 0.5 more days per week by week 20).

conclusionsThose who co-use cannabis and cigarettes may still be at risk for greater exposure to non-tobacco-specific toxicants and carcinogens compared to those who only smoke cigarettes. IMPLICATIONS: The present study is the longest longitudinal, prospective comparison study of smoking behavior and exposure to harmful constituents among those who co-use cigarettes and cannabis versus cigarette-only after immediately switching to very low nicotine content cigarettes (VLNC). Those who co-use experienced similar reductions in CPD and tobacco-specific exposure, compared to those who only use cigarettes. However, co-use groups experienced smaller reductions in non-tobacco-specific toxicants and carcinogens compared to the cigarette-only group, potentially because of combustible cannabis use. Additionally, those who co-use and switched to VLNC may be susceptible to slight increases in cannabis use (approximately two more days per year).

Indexed as

CannabisSmoking CessationTobacco ProductsBiomarkersCarcinogensHumansNicotineBiomarkersCarcinogensNicotine

Identifiers

PMID36198098
PMCPMC10077930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.